AveXis was founded by Brian Kaspar in 2012.

Who are AveXis's investors?

AveXis's investors include Foresite Capital, PBM Capital, RA Capital, Sofinnova Ventures.

How much funding has AveXis raised?

AveXis has disclosed $65M raised across 1 round.

AveXis is headquartered in Bannockburn, US.

Bannockburn, US · Founded 2012 · 4 known investors

New gene therapy treatments for people with serious, rare diseases. (NASDAQ: BOLD) (Acquired by Astellas)

AveXis was founded in 2012 by Brian Kaspar.

Brian KasparFounder

James L'ItalienExecutive

Andrew F. KnudtenExecutive

Sukumar NagendranExecutive

Thomas DeeExecutive

Sean NolanExecutive

Paul Manning inBoard directorChairman and CEO at PBM Capital

Bong KohBoard director

Carole NuechterlainBoard director

Jonathan Leff inBoard directorExecutive Partner, Private Equity at Sofinnova Ventures

John D. HarkeyBoard director

Form D private placements

$65M disclosed across 1 round · 2015

▶$65MraisedSep 2015 · 27 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

What does AveXis do?: New gene therapy treatments for people with serious, rare diseases. (NASDAQ: BOLD) (Acquired by Astellas)
Who founded AveXis?: AveXis was founded by Brian Kaspar in 2012.
Who are AveXis's investors?: AveXis's investors include Foresite Capital, PBM Capital, RA Capital, Sofinnova Ventures.
How much funding has AveXis raised?: AveXis has disclosed $65M raised across 1 round.
Where is AveXis headquartered?: AveXis is headquartered in Bannockburn, US.